Nicolò Reccardini

8PUBLICATIONS
18CO-AUTHORS
AllergyImmunogenetics (incl. genetic immunology)Predictive and prognostic markersNeurology and neuromuscular diseasesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 27, 2025
Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice.

Alessia Giovanna Andrisano, Nadia Castaldo, Francesco Giuliana

|Mar 27, 2025
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis.

Stefano Kette, Nicolò Reccardini, Francesco Salton

|Sep 28, 2024
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease.

Marta Maggisano, Lucrezia Mondini, Maria Chernovsky

|Jul 27, 2024
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant.

Nicolò Reccardini, Maria Chernovsky, Francesco Salton

|Jun 27, 2024
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows.

Maria Chianese, Gianluca Screm, Francesco Salton

Pageof 2